Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Shares Issued: 2021-2023

Historic Shares Issued for ADC Therapeutics (ADCT) over the last 2 years, with Dec 2023 value amounting to -$1,000.

  • ADC Therapeutics' Shares Issued fell 100.02% to -$1,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $6.9 million, marking a year-over-year decrease of 0.07%. This contributed to the annual value of $60.5 million for FY2024, which is 7727.43% up from last year.
  • According to the latest figures from Q4 2023, ADC Therapeutics' Shares Issued is -$1,000, which was down 100.29% from $349,000 recorded in Q3 2023.
  • ADC Therapeutics' Shares Issued's 5-year high stood at $6.1 million during Q4 2022, with a 5-year trough of -$1,000 in Q4 2023.
  • In the last 3 years, ADC Therapeutics' Shares Issued had a median value of $174,641 in 2021 and averaged $959,351.
  • Its Shares Issued has fluctuated over the past 5 years, first skyrocketed by 687.64% in 2022, then slumped by 100.02% in 2023.
  • Over the past 3 years, ADC Therapeutics' Shares Issued (Quarterly) stood at $777,484 in 2021, then spiked by 687.64% to $6.1 million in 2022, then slumped by 100.02% to -$1,000 in 2023.
  • Its Shares Issued stands at -$1,000 for Q4 2023, versus $349,000 for Q3 2023 and $425,000 for Q1 2023.